Regression of skeletal metastases from hypernephroma following long-term treatment with medroxyprogesterone acetate.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000556:secondary*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary*; D006801:Humans; D007680:Kidney Neoplasms; D008297:Male; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D008875:Middle Aged
D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone